Solta Medical Announces Isolaz 2 Acne System
HAYWARD, Calif., June 3, 2013 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced Isolaz® 2, the next generation acne therapy device. Isolaz 2 effectively targets the root causes of acne through a unique, clinically proven combination of vacuum extraction for deep pore purification, broadband light to destroy acne causing bacteria, and a profusion mode to enhance the delivery of topicals into the skin.
"The Isolaz technology is an invaluable tool that sets me apart as a skin specialist; these days, patients want non-systemic and no downtime yet effective acne treatments and Isolaz technology offers all of the above," said Dr. Kenneth Beer , MD., PA., founder of Kenneth Beer MD PA, General, Cosmetic And Surgical Dermatology and voluntary assistant professor at the University of Miami and a consulting associate in the Department of Medicine at Duke University. "The new disposable tips in a variety of sizes offer more options for speed, safety and comfort, expanding treatment area options to include the face, back and chest. With the Isolaz 2 system, physicians can offer safe acne treatments for individual patient needs. I have used the Isolaz technology with great efficacy on many of my patients as well as on my sons."
Isolaz 2 uses Intense Pulsed Light (IPL) therapy combined with vacuum technology clinical proven to safely and effectively treat acne in a three-step process – Cleanse, Purify, Replenish. First, a vacuum removes sebaceous materials to cleanse the pores; second, broadband light purifies by destroying acne-causing bacteria; third, skincare topicals are infused into the skin for a replenishing effect.